The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. (Record no. 25817839)

MARC details
000 -LEADER
fixed length control field 01434 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517084049.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201607s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0392-856X
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hodge, Jennifer A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160721
245 00 - TITLE STATEMENT
Title The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical and experimental rheumatology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 318-28 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arthritis, Rheumatoid
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytokines
General subdivision physiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocyte Subsets
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neutrophils
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision physiology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kawabata, Thomas T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krishnaswami, Sriram
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clark, James D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Telliez, Jean-Baptiste
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dowty, Martin E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Menon, Sujatha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lamba, Manisha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zwillich, Samuel
773 0# - HOST ITEM ENTRY
Title Clinical and experimental rheumatology
Related parts vol. 34
-- no. 2
-- p. 318-28

No items available.